Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
3933.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
-36%
0.13
vs 0.21
Q4.20
+35%
0.32
vs 0.24
Q2.21
+209%
0.41
vs 0.13
Q4.21
-25%
0.24
vs 0.32
Q2.22
-1%
0.4
vs 0.41
Q4.22
+145%
0.6
vs 0.24
Q2.23
+89%
0.76
vs 0.4
Q4.23
+45%
0.86
vs 0.6
Q2.24
+15%
0.88
vs 0.76
Q4.24
-21%
0.68
vs 0.86
Sales Growth
YoY
Current
Estimates
Q2.20
+5%
4.3B vs 4.1B
Q4.20
+4%
4.5B vs 4.3B
Q2.21
+10%
4.7B vs 4.3B
Q4.21
+12%
5B vs 4.5B
Q2.22
+10%
5.2B vs 4.7B
Q4.22
+23%
6.2B vs 5B
Q2.23
+33%
6.9B vs 5.2B
Q4.23
+11%
6.8B vs 6.2B
Q2.24
+4%
7.2B vs 6.9B
Q4.24
-4%
6.6B vs 6.8B
Return on Equity
QoQ
Q2.21
+7%
0.07
vs 0.06
Q4.21
+4%
0.04
vs 0.07
Q2.22
+6%
0.06
vs 0.04
Q4.22
+9%
0.09
vs 0.06
Q2.23
+11%
0.11
vs 0.09
Q4.23
+11%
0.11
vs 0.11
Q2.24
+11%
0.11
vs 0.11
Q4.24
+8%
0.08
vs 0.11
Institutionnal Ownership
QoQ
Q3.20
1
1
vs NA
NA
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
HKSE
0.22Â ( 1.42%)
Relative Strenght
Volume Buzz
-49%
Earning Acce
No
Dist 52w H.
12%Forecast
147%2025-Revenue
218%2025-EPS
184%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
3933.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 3933.HK compares to sector?